Therapeutic Strategies for Spinocerebellar Ataxia Type 1
Biomolecules · 2023
DOI: 10.3390/biom13050788 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, 2023. Verfasst von Laurie M C Kerkhof und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands. Hauptthemen laut MEDLINE: Cerebellum, Spinocerebellar Ataxias. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch brain foundation, ZonMW PSIDER project, ZonMw Pto2.
Abstract (Originalsprache)
: Spinocerebellar ataxia type 1 (SCA1) is an autosomal dominant neurodegenerative disorder that affects one or two individuals per 100,000. The disease is caused by an extended CAG repeat in exon 8 of the ATXN1 gene and is characterized mostly by a profound loss of cerebellar Purkinje cells, leading to disturbances in coordination, balance, and gait. At present, no curative treatment is available for SCA1. However, increasing knowledge on the cellular and molecular mechanisms of SCA1 has led the way towards several therapeutic strategies that can potentially slow disease progression. SCA1 therapeutics can be classified as genetic, pharmacological, and cell replacement therapies. These different therapeutic strategies target either the (mutant) ATXN1 RNA or the ataxin-1 protein, pathways that play an important role in downstream SCA1 disease mechanisms or which help restore cells that are lost due to SCA1 pathology. In this review, we will provide a summary of the different therapeutic strategies that are currently being investigated for SCA1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Human Genetics, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
- Dutch Center for RNA Therapeutics, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
- Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
ORCID-Profile: Laurie M C Kerkhof, Bart P C van de Warrenburg, Willeke M C van Roon-Mom, Ronald A M Buijsen
Förderung
- Dutch brain foundation
- ZonMW PSIDER project
- ZonMw Pto2
Zitieren
APA
Kerkhof, L. M. C., van de Warrenburg, B. P. C., van Roon-Mom, W. M. C., & Buijsen, R. A. M. (2023). Therapeutic Strategies for Spinocerebellar Ataxia Type 1. Biomolecules. https://doi.org/10.3390/biom13050788
Vancouver
Kerkhof LMC, van de Warrenburg BPC, van Roon-Mom WMC, Buijsen RAM. Therapeutic Strategies for Spinocerebellar Ataxia Type 1. Biomolecules. 2023. doi:10.3390/biom13050788
BibTeX
@article{Kerkhof2023,
author = {Kerkhof, Laurie M C and van de Warrenburg, Bart P C and van Roon-Mom, Willeke M C and Buijsen, Ronald A M},
title = {Therapeutic Strategies for Spinocerebellar Ataxia Type 1},
journal = {Biomolecules},
year = {2023},
doi = {10.3390/biom13050788}
}
EUVIMED